WHF IASC Roadmap on Chagas Disease.

Chagas Disease / epidemiology Global Health Humans Morbidity / trends Practice Guidelines as Topic World Health Organization
Chagas disease cardiomyopathy heart failure neglected tropical disease

Journal

Global heart
ISSN: 2211-8179
Titre abrégé: Glob Heart
Pays: England
ID NLM: 101584391

Informations de publication

Date de publication:
30 03 2020
Historique:
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 14 4 2021
Statut: epublish

Résumé

Chagas Disease is a neglected tropical disease caused by the protozoan In a collaboration of the World Hearth Federation (WHF) and the Inter-American Society of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation. The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy. The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.

Sections du résumé

Background
Chagas Disease is a neglected tropical disease caused by the protozoan
Methods
In a collaboration of the World Hearth Federation (WHF) and the Inter-American Society of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation.
Results
The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy.
Conclusion
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.

Identifiants

DOI: 10.5334/gh.484 PMID: 32489799 PMC: PMC7218776
pubmed: 32489799
doi: 10.5334/gh.484
pmc: PMC7218776
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Informations de copyright

Copyright: © 2020 The Author(s).

Déclaration de conflit d'intérêts

MLF has received financial support for inscription to an international meeting from Philips/Agimed Argentina. RM previously worked in a consultancy role for Exeltis and Bayer. GM has received grants for global health research and projects from Novartis. LEE has received a research grant for work on Chagas cardiomyopathy from Roche. He is also a member of the steering committee of the PARACHUTE-HF trial.

Références

Glob Heart. 2015 Jun;10(2):111-22
pubmed: 26213298
Lancet. 2010 Apr 17;375(9723):1388-402
pubmed: 20399979
Rev Panam Salud Publica. 2019 Sep 20;43:e74
pubmed: 31582959
Sci Rep. 2018 Jul 26;8(1):11292
pubmed: 30050153
Curr Opin Infect Dis. 2006 Dec;19(6):583-7
pubmed: 17075335
Curr Mol Med. 2008 Sep;8(6):510-8
pubmed: 18781958
Expert Rev Clin Pharmacol. 2018 Oct;11(10):943-957
pubmed: 30111183
PLoS Negl Trop Dis. 2014 Oct 30;8(10):e3245
pubmed: 25357193
PLoS Negl Trop Dis. 2016 Nov 7;10(11):e0005033
pubmed: 27820837
Acta Trop. 2010 Jul-Aug;115(1-2):22-7
pubmed: 19646412
Curr Opin Infect Dis. 2014 Oct;27(5):418-24
pubmed: 25023742
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):507-9
pubmed: 25993401
Clin Infect Dis. 2010 Nov 15;51(10):e69-75
pubmed: 20932171
PLoS Negl Trop Dis. 2013;7(1):e1965
pubmed: 23349998
Am J Trop Med Hyg. 2015 Jul;93(1):108-13
pubmed: 25986581
Lancet. 2018 Jan 6;391(10115):82-94
pubmed: 28673423
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312
pubmed: 25411847
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2304
pubmed: 23875039
PLoS Negl Trop Dis. 2014 Jun 05;8(6):e2801
pubmed: 24901942
BMJ Glob Health. 2018 Oct 11;3(5):e001069
pubmed: 30364393
Elife. 2018 Mar 26;7:
pubmed: 29578409
Front Immunol. 2018 Dec 03;9:2791
pubmed: 30559742
Infect Immun. 2018 Mar 22;86(4):
pubmed: 29311242
J Am Coll Cardiol. 2017 Sep 19;70(12):1510-1524
pubmed: 28911515
J Card Fail. 2014 Dec;20(12):931-8
pubmed: 25230241
Lancet Infect Dis. 2001 Sep;1(2):92-100
pubmed: 11871482
Rev Soc Bras Med Trop. 2007 Jan-Feb;40(1):1-10
pubmed: 17486245
Int J Infect Dis. 2018 Aug;73:93-101
pubmed: 29879524
Am J Public Health. 2013 Nov;103(11):1968-78
pubmed: 24028246
Med Clin (Barc). 2017 Feb 9;148(3):125-131
pubmed: 27993415
Rev Bras Hematol Hemoter. 2012;34(4):292-7
pubmed: 23049443
PLoS Negl Trop Dis. 2017 Aug 18;11(8):e0005770
pubmed: 28820896
Rev Soc Bras Med Trop. 2011 Nov-Dec;44(6):762-70
pubmed: 22231251
J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):461-469
pubmed: 31016324
Am J Trop Med Hyg. 2010 May;82(5):838-45
pubmed: 20439964
PLoS Negl Trop Dis. 2016 Mar 14;10(3):e0004508
pubmed: 26974551
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2410
pubmed: 24069473
Stroke Vasc Neurol. 2017 Jun 21;2(4):230-243
pubmed: 29507784
Glob Heart. 2015 Jun;10(2):123-33
pubmed: 26213299
Transplant Rev (Orlando). 2011 Jul;25(3):91-101
pubmed: 21530219
Int J Cardiol. 2017 Jan 15;227:577-582
pubmed: 27839809
Diagn Microbiol Infect Dis. 2017 Sep;89(1):26-28
pubmed: 28684052
Am J Trop Med Hyg. 2010 Oct;83(4):891-5
pubmed: 20889886
Clin Infect Dis. 2012 Mar;54(6):845-52
pubmed: 22238161
HIV Clin Trials. 2011 Nov-Dec;12(6):287-98
pubmed: 22189148
Soc Sci Med. 2017 Feb;175:187-198
pubmed: 28107703
Trans R Soc Trop Med Hyg. 2010 Jul;104(7):447-52
pubmed: 20303560
Emerg Infect Dis. 2010 May;16(5):871-2
pubmed: 20409389
Transplant Proc. 2010 Nov;42(9):3354-9
pubmed: 21094779
Parasit Vectors. 2018 Apr 10;11(1):233
pubmed: 29636097
Mem Inst Oswaldo Cruz. 2015 May;110(3):414-21
pubmed: 25993507
Am J Trop Med Hyg. 2014 Nov;91(5):915-9
pubmed: 25200261
PLoS Negl Trop Dis. 2011 Oct;5(10):e1250
pubmed: 22039554
PLoS Negl Trop Dis. 2017 Jan 18;11(1):e0005251
pubmed: 28099488
Arq Bras Cardiol. 2011 Jun;96(6):434-42
pubmed: 21789345
J Antimicrob Chemother. 2003 Sep;52(3):441-9
pubmed: 12917253
Mem Inst Oswaldo Cruz. 2013 Apr;108(2):251-4
pubmed: 23579810
PLoS Negl Trop Dis. 2009 Jul 07;3(7):e484
pubmed: 19582163
PLoS Negl Trop Dis. 2019 Aug 29;13(8):e0007668
pubmed: 31465522
Glob Heart. 2019 Sep;14(3):215-240
pubmed: 31451236
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16194-9
pubmed: 17913895
Circ Heart Fail. 2017 Nov;10(11):
pubmed: 29141857
Infect Dis Clin North Am. 2019 Mar;33(1):119-134
pubmed: 30712757
Int J Parasitol. 2019 Mar;49(3-4):301-310
pubmed: 30738925
Acta Trop. 2018 Aug;184:59-66
pubmed: 29476727
Pediatrics. 2011 Jan;127(1):e212-8
pubmed: 21173000
N Engl J Med. 2014 May 15;370(20):1899-908
pubmed: 24827034
Arch Dis Child. 2015 Jan;100(1):90-4
pubmed: 25210104
PLoS One. 2015 Oct 05;10(10):e0139363
pubmed: 26436678
Rev Esp Cardiol. 2007 Mar;60(3):285-93
pubmed: 17394874
Glob Heart. 2017 Mar;12(1):47-62
pubmed: 28336386
Arq Bras Cardiol. 2008 Nov;91(5):306-10
pubmed: 19142374
Emerg Infect Dis. 2009 Apr;15(4):653-5
pubmed: 19331764
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
Transplantation. 2018 Feb;102(2S Suppl 2):S1-S7
pubmed: 29381572
Gastroenterol Hepatol. 2010 Mar;33(3):191-200
pubmed: 19837482
Front Immunol. 2018 Sep 13;9:1958
pubmed: 30271399
Acta Trop. 2011 May;118(2):110-7
pubmed: 21396345
Heart. 2019 Feb;105(4):283-290
pubmed: 30181202
J Mol Diagn. 2017 Sep;19(5):673-681
pubmed: 28727985
J Am Soc Echocardiogr. 2018 Jan;31(1):3-25
pubmed: 29306364
Medicina (B Aires). 1985;45(5):553-8
pubmed: 3939553
Lancet Infect Dis. 2018 Apr;18(4):419-430
pubmed: 29352704
J Am Coll Cardiol. 2017 Feb 28;69(8):939-947
pubmed: 28231946
Expert Rev Anti Infect Ther. 2019 Mar;17(3):145-157
pubmed: 30712412
PLoS Negl Trop Dis. 2018 Jun 13;12(6):e0006567
pubmed: 29897909
Rev Soc Bras Med Trop. 2016 Dec;49Suppl 1(Suppl 1):3-60
pubmed: 27982292
Am J Trop Med Hyg. 2004 Feb;70(2):210-20
pubmed: 14993635
Am J Trop Med Hyg. 2018 Mar;98(3):735-741
pubmed: 29380723
Qual Life Res. 2011 Feb;20(1):133-8
pubmed: 21046258
Am J Trop Med Hyg. 1998 Sep;59(3):487-91
pubmed: 9749649
J Med Entomol. 2012 Nov;49(6):1379-86
pubmed: 23270166
BMC Res Notes. 2015 Sep 29;8:508
pubmed: 26419230
Glob Heart. 2017 Dec;12(4):273-284
pubmed: 28336387
Trans R Soc Trop Med Hyg. 1987;81(3):437-40
pubmed: 3120369
PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005783
pubmed: 28892479
Am Heart J. 2007 Apr;153(4):544.e1-8
pubmed: 17383291
PLoS Negl Trop Dis. 2019 Aug 15;13(8):e0007647
pubmed: 31415566
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:181-6
pubmed: 19753473
Am J Trop Med Hyg. 2009 Mar;80(3):410-5
pubmed: 19270291
PLoS Negl Trop Dis. 2018 Nov 1;12(11):e0006814
pubmed: 30383777
Clin Infect Dis. 2009 Dec 1;49(11):1667-74
pubmed: 19877966
Clin Infect Dis. 1999 Sep;29(3):561-7
pubmed: 10530448
Int J Cardiol. 2010 Nov 19;145(2):362-363
pubmed: 20399519
Glob Heart. 2015 Sep;10(3):139-44
pubmed: 26407508
J Parasitol. 2005 Dec;91(6):1468-73
pubmed: 16539033
Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1393-409
pubmed: 26496376
Am J Trop Med Hyg. 1998 Oct;59(4):526-9
pubmed: 9790423
Clin Microbiol Infect. 2014 Apr;20(4):300-9
pubmed: 24602129
Methods Mol Biol. 2019;1955:179-186
pubmed: 30868527
Circulation. 2018 Sep 18;138(12):e169-e209
pubmed: 30354432
Circulation. 1956 Dec;14(6):1035-60
pubmed: 13383798
PLoS Negl Trop Dis. 2013 Oct 17;7(10):e2488
pubmed: 24147169
Vaccine. 2016 Jun 3;34(26):2996-3000
pubmed: 27026146
N Engl J Med. 2015 Oct;373(14):1295-306
pubmed: 26323937
Am J Trop Med Hyg. 2018 Jun;98(6):1733-1742
pubmed: 29714163
PLoS Negl Trop Dis. 2010 May 18;4(5):e688
pubmed: 20502520
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:17-30
pubmed: 19753454
Trop Med Int Health. 2000 Apr;5(4):293-301
pubmed: 10810029
PLoS Negl Trop Dis. 2013 Aug 01;7(8):e2358
pubmed: 23936581
PLoS Negl Trop Dis. 2017 Jul 20;11(7):e0005779
pubmed: 28727723
Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):484-7
pubmed: 19967227
PLoS Negl Trop Dis. 2007 Nov 07;1(2):e114
pubmed: 18060077
Ann Intern Med. 2006 May 16;144(10):724-34
pubmed: 16702588
Lancet Infect Dis. 2013 Apr;13(4):342-8
pubmed: 23395248
PLoS Negl Trop Dis. 2017 May 18;11(5):e0005542
pubmed: 28545053
Cad Saude Publica. 2001;17 Suppl:89-97
pubmed: 11426269
Glob Heart. 2015 Sep;10(3):167-72
pubmed: 26407512
Rev Soc Bras Med Trop. 2008 Nov-Dec;41(6):602-14
pubmed: 19142440
Expert Rev Anti Infect Ther. 2014 Apr;12(4):479-96
pubmed: 24621252
J Antimicrob Chemother. 2017 Sep 1;72(9):2596-2601
pubmed: 28645201
PLoS Negl Trop Dis. 2017 Apr 5;11(4):e0005507
pubmed: 28379959

Auteurs

Luis Eduardo Echeverría (LE)

Department of Cardiology, Cardiovascular Foundation of Colombia, Floridablanca, CO.

Rachel Marcus (R)

LASOCHA, Washington DC, US.
Medstar Union Memorial Hospital, Baltimore, MD, US.

Gabriel Novick (G)

Swiss Medical Group, Buenos Aires, AR.
Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, US.

Sergio Sosa-Estani (S)

Drugs for Neglected Diseases initiative-Latin America, Rio de Janeiro, BR.

Kate Ralston (K)

World Heart Federation, Geneva, CH.

Ezequiel Jose Zaidel (EJ)

Sanatorio Güemes, Buenos Aires, AR.
Pharmacology Department, School of Medicine, University of Buenos Aires, Buenos Aires, AR.

Colin Forsyth (C)

Drugs for Neglected Diseases initiative-Latin America, Rio de Janeiro, BR.

Antonio Luiz P RIbeiro (ALP)

Internal Medicine Department, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, BR.
Hospital das Clínicas, UFMG, Belo Horizonte, BR.

Iván Mendoza (I)

Central University of Venezuela, Caracas, VE.

Mariano Luis Falconi (ML)

Cardiology Division, Italian Hospital of Buenos Aires, Buenos Aires, AR.
University Institute of the Italian Hospital of Buenos Aires, Buenos Aires, AR.

Jorge Mitelman (J)

Faculty of Medicine, University of Buenos Aires, Buenos Aires, AR.
School of Medicine, Barcélo University, Buenos Aires, AR.

Carlos A Morillo (CA)

Department of Cardiac Sciences, Cumming School of Medicine Division of Cardiology, Libin Cardiovascular Institute, University of Calgary, Calgary, CA.
Southeastern Alberta Region, Alberta Health Services, Foothills Medical Centre, CA.

Ana Cristina Pereiro (AC)

Mundo Sano Foundation, Buenos Aires, AR.

María Jesús Pinazo (MJ)

ISGlobal, Hospital Clínic, University of Barcelona, Barcelona, ES.

Roberto Salvatella (R)

PAHO/WHO, Montevideo, UY.

Felipe Martinez (F)

National University of Cordoba, Cordoba, AR.
DAMIC Institute/Rusculleda Foundation, Cordoba, AR.

Pablo Perel (P)

World Heart Federation, Geneva, CH.
Centre for Global Chronic Conditions, London School of Hygiene and Tropical Medicine, London, GB.

Álvaro Sosa Liprandi (ÁS)

Sanatorio Güemes, Buenos Aires, AR.
Medical School of Cardiology, University of Buenos Aires, Buenos Aires, AR.

Daniel José Piñeiro (DJ)

Faculty of Medicine, University of Buenos Aires, Buenos Aires, AR.

Gustavo Restrepo Molina (GR)

School of Medicine, CES University, Medellín, CO.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Infection › Maladies vectorielles › Maladie de Chagas › WHF IASC Roadmap on Chagas Disease.
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mondiale › WHF IASC Roadmap on Chagas Disease.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › WHF IASC Roadmap on Chagas Disease.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › WHF IASC Roadmap on Chagas Disease.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › WHF IASC Roadmap on Chagas Disease.
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Agences internationales › Nations Unies › Organisation mondiale de la santé › WHF IASC Roadmap on Chagas Disease.